Inloggen
Inloggen
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registreer
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

IONIS PHARMACEUTICALS, INC.

(IONS)
  Rapport
Vertraagde tijd Nasdaq  -  22:00 29-11-2022
38.76 USD   -3.89%
14/11Ionis Pharmaceuticals, Inc. Samenwerking met Metagenomi om genbewerking toe te voegen aan zijn brede technologieplatform
CI
10/11Ionis Pharmaceuticals, Inc. : SVB Securities LLC handhaaft het Neutraal advies
MM
10/11Ionis Pharmaceuticals, Inc. : Citigroup is niet overtuigd
MM
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproductenFonds 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiŽle publicatiesSectornieuws
Dagen
:
Uren
:
Minuten
:
Seconden
Nieuws in andere talen op IONIS PHARMACEUTICALS, INC.
29/11Transcript : Ionis Pharmaceuticals, Inc. Presents at Piper Sandler 34th Annua..
29/11Transcript : Ionis Pharmaceuticals, Inc. Presents at 5th Annual Evercore ISI ..
15/11Transcript : Ionis Pharmaceuticals, Inc. Presents at Stifel 2022 Healthcare C..
14/11Transcript : Ionis Pharmaceuticals, Inc. Presents at Guggenheim Healthcare Ta..
14/11Ionis presents positive Phase 2 data from open label extension study of donidalorsen at..
14/11Ionis Pharmaceuticals : View Presentation
14/11Transcript : Ionis Pharmaceuticals, Inc. - Special Call
14/11Ionis Pharmaceuticals, Metagenomi Sign Collaboration Deal To Produce Investigational Me..
14/11Ionis Pharmaceuticals : Material Agreement - Form 8-K
14/11Ionis partners with Metagenomi to add gene editing to its broad technology platform
14/11Ionis Pharmaceuticals, Inc. Partners with Metagenomi to Add Gene Editing to its Broad T..
10/11Ionis reports third quarter financial results
10/11Ionis to present at upcoming investor conferences
09/11IONIS PHARMACEUTICALS INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION ..
09/11Ionis Pharmaceuticals : 3Q22 Earnings Slides
09/11Transcript : Ionis Pharmaceuticals, Inc., Q3 2022 Earnings Call, Nov 09, 2022
09/11Sector Update: Health Care Stocks Mixed Pre-Bell Wednesday
09/11Ionis Pharmaceuticals Q3 Loss Narrows as Revenue Grows
09/11Earnings Flash (IONS) IONIS PHARMACEUTICALS Reports Q3 Revenue $160M
09/11Ionis Pharmaceuticals : Q3 Earnings Snapshot
09/11Ionis Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Mon..
09/11Ionis Pharmaceuticals, Inc. Provides Revenue Guidance for the Full Year 2022
09/11North American Morning Briefing: Midterm Outcome -2-
08/11Ionis Pharmaceuticals Says Bepirovirsen Improves Chronic Hepatitis B Virus Symptoms in ..
08/11Ionis Pharmaceuticals, Inc. Announces Positive Data from GSK's Phase 2b Clinical Study ..
08/11Ionis presents positive Phase 2 data in patients with IgA Nephropathy at American Socie..
07/11Ionis announces positive results from fesomersen development program
07/11Roche : critère d'évaluation atteint chez Ionis
07/11Ionis Pharmaceuticals, Inc. Presents Positive Phase 2 Data in Patients with IgA Nephrop..
04/11Ionis Pharmaceuticals Says Fesomersen, Developed With Bayer for Prevention of Thrombosi..
04/11Ionis Pharmaceuticals Inc : Termination of a Material Definitive Agreement, Financial Stat..
04/11Ionis Pharmaceuticals, Inc. Announces Positive Results from Fesomersen Development Prog..
26/10Ionis to hold third quarter 2022 financial results webcast
24/10Ionis Pharmaceuticals Inc : Entry into a Material Definitive Agreement, Creation of a Dire..
24/10Oxford Properties Group, Inc. acquired 18.4-Acre Life Science Campus and Corporate Head..
12/10Ionis Pharmaceuticals Signs Deal With Sudberry Properties for New California Production..
12/10Ionis Pharmaceuticals Inc : Entry into a Material Definitive Agreement (form 8-K)
12/10Ionis announces plan for new manufacturing facility in Oceanside, Calif.
12/10Ionis Pharmaceuticals, Inc. Enters into an Agreement with Sudberry Properties to Develo..
26/09L'éléphant dans la pièce
26/09Bolsa de Madrid: El elefante en la habitación
26/09EN DIRECT DES MARCHES : TotalEnergies, Airbus, Eurofins, Alstom, M..
26/09AstraZeneca Junks Ionis' Cholesterol Drug After Failing To Reach Efficacy Threshold In ..
23/09Sector Update: Health Care Stocks Retreat Pre-Bell Friday
23/09Sector Update: Health Care
23/09AstraZeneca : arrêt d'un programme anticholestérol avec Ionis
23/09Ionis Pharmaceuticals Says Hypercholesterolemia Drug Will Not Advance to Phase 3 After ..
23/09Ionis provides update on development program evaluating PCSK9 antisense medicine for th..
23/09Ionis Pharmaceuticals, Inc. Provides Update on Development Program Evaluating PCSK9 Ant..
12/09Transcript : Ionis Pharmaceuticals, Inc. Presents at Morgan Stanley 20th Annu..
12/09North American Morning Briefing: Mood Improves as -3-
09/09Ionis Pharmaceuticals Shares Rise After Morgan Stanley Upgrade
08/09Transcript : Ionis Pharmaceuticals, Inc. Presents at Citi's 17th Annual BioPh..
08/09AstraZeneca-Ionis' Rare Disease Drug Improves Neuropathy Impairment In Late-stage Study
07/09Transcript : Ionis Pharmaceuticals, Inc. Presents at 2022 Wells Fargo Healthc..
07/09AstraZeneca : des résultats de phase 3 positifs avec Ionis
07/09Ionis, AstraZeneca's Phase 3 Trial of Amyloidosis Drug Meets Endpoints
07/09Ionis presents positive results from Phase 3 NEURO-TTRansform study at International Sy..
07/09Ionis Pharmaceuticals, Inc. Presents Positive Results from Phase 3 Neuro-Ttransform Stu..
31/08Ionis Pharmaceuticals to present at upcoming investor conferences
30/08Ionis to present at upcoming investor conferences
10/08Ionis reports second quarter financial results and recent business achievements
09/08IONIS PHARMACEUTICALS INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION ..
09/08Ionis Pharmaceuticals : 2Q22 Earnings Slides
09/08Ionis Pharmaceuticals : reports second quarter financial results and recent business achie..
09/08Transcript : Ionis Pharmaceuticals, Inc., Q2 2022 Earnings Call, Aug 09, 2022
09/08Ionis Pharmaceuticals, Inc. Provides Earnings Guidance for the Year 2022
09/08Ionis Pharmaceuticals Reports Higher Q2 Revenue, Wider Loss
09/08Ionis Pharmaceuticals : Q2 Earnings Snapshot
09/08Earnings Flash (IONS) IONIS PHARMACEUTICALS Posts Q2 Revenue $134M
09/08Ionis Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Mon..
09/08North American Morning Briefing: Stocks to -2-
28/07Ionis Pharmaceuticals Says Phase 2b Study of Investigational Drug Met Primary Endpoint ..
28/07Ionis announces positive topline results from Phase 2b clinical study of fesomersen, a ..
28/07Ionis Pharmaceuticals, Inc. Announces Positive Topline Results from Phase 2B Clinical S..
28/07Ionis Pharmaceuticals Inc : Notice of Delisting or Failure to Satisfy a Continued Listing ..
27/07Ionis to hold second quarter 2022 financial results webcast
26/07Biogen Says US FDA Accepts NDA, Grants Priority Review for Amyotrophic Lateral Sclerosi..
26/07U.S. FDA accepts Biogen's ALS therapy for review
26/07U.S. FDA grants priority review to Biogen's ALS drug
26/07Ionis announces that FDA accepts New Drug Application and grants Priority Review of tof..
26/07Ionis Pharmaceuticals, Inc. Announces FDA Accepts New Drug Application and Grants Prior..
26/07Biogen Gets FDA Priority Review of Tofersen in Rare Form of ALS
20/07Transcript : Ionis Pharmaceuticals, Inc. Presents at H.C. Wainwright 1st Annu..
20/07Sector Update: Health Care Stocks Mixed Premarket Wednesday
20/07Ionis Pharmaceuticals Completes Patient Enrollment in Phase 3 Study for Cardiovascular ..
20/07Ionis announces enrollment completion of Phase 3 Lp(a) HORIZON cardiovascular outcomes ..
20/07Ionis Announces Enrollment Completion of Phase 3 Lp(a) HORIZON Cardiovascular Outcomes ..
19/07Ionis Pharmaceuticals : IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE - Form 8-K
19/07Ionis Pharmaceuticals Inc : Other Events, Financial Statements and Exhibits (form 8-K)
18/07Ionis Pharmaceuticals : Management Change/Compensation - Form 8-K
18/07Frederick Muto Retires from Ionis Pharmaceuticals, Inc., Effective July 15, 2022
18/07Ionis Pharmaceuticals Inc : Change in Directors or Principal Officers (form 8-K)
13/07Ionis to participate in virtual fireside chat at H.C. Wainwright 1st Annual Hereditary ..
11/07Ionis Pharmaceuticals : partner licenses rare kidney disease treatment and will advance in..
11/07Ionis Pharmaceuticals Inc : Entry into a Material Definitive Agreement, Financial Statemen..
11/07Ionis Pharmaceuticals' Partner Licenses Rare Kidney Disease Treatment, to Advance Into ..
11/07Ionis partner licenses rare kidney disease treatment and will advance into Phase 3 clin..
11/07Ionis Partner Licenses Rare Kidney Disease Treatment and Will Advance into Phase 3 Clin..
27/06Ionis announces presentation of positive Phase 2b data for chronic hepatitis B treatmen..
Volgende evenement op IONIS PHARMACEUTICALS, INC.